Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid

Overview of attention for article published in Journal of Translational Medicine, December 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 60 Dimensions

Readers on

mendeley: 54 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

COMPOSITION COMPRISING INTERFERON GAMMA AND AN HDAC INHIBITOR OR GONADOTROPIN RECEPTOR…

Application EP-3238726-A3

European Patent Office

CANCER MARKERS

Application WO-2012130478-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.